| 注册
首页|期刊导航|医药导报|玉郎伞多糖对药物性肝损伤小鼠的保护作用

玉郎伞多糖对药物性肝损伤小鼠的保护作用

阮文福 段文明 梁杏梅 陈兆霓 黄仁彬

医药导报Issue(7):866-870,5.
医药导报Issue(7):866-870,5.DOI:10.3870/yydb.2015.07.005

玉郎伞多糖对药物性肝损伤小鼠的保护作用

Protective Effect of Yulangsan Polysaccharide Against Hepatic Injury in Mice

阮文福 1段文明 1梁杏梅 1陈兆霓 1黄仁彬1

作者信息

  • 1. 广西医科大学药理学教研室,南宁 530021
  • 折叠

摘要

Abstract

Objective To investigate the protective effect of Yulangsan polysacharide ( YLSPS) and mechanism against ibuprofen-induced liver injury in mice. Methods The mice were randomly divided into the blank control(NC), the model control,YLSPS at 150 mg·kg-1 , 300 mg·kg-1 ,600 mg·kg-1 groups and biphenyldicarboxylate (150 mg·kg-1 BPDC) group. The mice were orally administered with corresponding agents once per day for consecutive 14 days, whereas the blank control group and model control group were orally administered with saline. Except the blank control group, all the other mice were orally administered IBU 200 mg·kg-1 body weight 2 h after last lavagedof medicimes. The mice were fasted and watered ad lib for 20 h after model establishment. Activities of ALT,AST and ALP,content of T-BiL,TNF-α,IL-6 in serum;activities of SOD,GSH-Px and content of MDA in liver tissue were detected. The morphological pathology test was used to examine degrees of hepatic injury. Results Compared with the model control, YLSPS could obviously reduce activities of ALT,AST and ALP,content of T-BiL, MDA,TNF-α and IL-6, and increase SOD,GSH-Px and CAT (P<0. 05), and then lessen the hepatic injury. Conclusion YLSPS showed potential protective effect against ibuprofen-induced liver injury in mice, the mechanism may be related to attenuating free radical injury and inhibiting lipid peroxidation and lowering release of inflammatory factors.

关键词

玉郎伞/多糖/布洛芬/保肝作用

Key words

Yulangsan/Polysaccharide/Ibuprofen/Hepatoprotection

分类

医药卫生

引用本文复制引用

阮文福,段文明,梁杏梅,陈兆霓,黄仁彬..玉郎伞多糖对药物性肝损伤小鼠的保护作用[J].医药导报,2015,(7):866-870,5.

基金项目

广西科学研究与科技开发攻关项目(10124008-6) (10124008-6)

广西地方性高发疾病防治研究重点实验室基金(KFJJ2010-22) (KFJJ2010-22)

广西科技基础条件平台建设项目(No.12-97-20) (No.12-97-20)

医药导报

OACSTPCD

1004-0781

访问量0
|
下载量0
段落导航相关论文